{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:49:03Z","timestamp":1794620943914,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T00:00:00Z","timestamp":1649548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T00:00:00Z","timestamp":1649548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangdong Basic and Applied Basic Research Foundation, China","award":["2018A030313584"],"award-info":[{"award-number":["2018A030313584"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province, China","award":["B2022208"],"award-info":[{"award-number":["B2022208"]}]},{"name":"Administration of Traditional Chinese Medicine of Guangdong Province, China","award":["20194002"],"award-info":[{"award-number":["20194002"]}]},{"name":"Administration of Traditional Chinese Medicine of Guangdong Province, China","award":["20222011"],"award-info":[{"award-number":["20222011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteoarthritis (OA) is a common degenerative joint disease, and chondrocyte extracellular matrix (ECM) degradation is one vital pathological feature of OA. Long noncoding RNA (lncRNA), a new kind of gene regulator, plays an important role in pathogenesis of many diseases like OA. Recent studies have confirmed that lncRNA plasmacytoma variant translocation 1 (PVT1) expression was upregulated in OA patients; however, its effect on ECM degradation remained unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cartilage tissue samples were obtained from 6 OA patients admitted in Guangdong Second Traditional Chinese Medicine Hospital. Chondrocytes were isolated and cultured from the collected cartilage tissue. Plasmid construction, RNA interference, cell transfection, fluorescence in situ hybridization (FISH), and pull-down assay were carried out during the research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this study, PVT1 expression was significantly increased in chondrocytes stimulated by interleukin-1\u03b2 (IL-1\u03b2). In addition, inhibition of PVT1 significantly downregulated the increased expressions of ADAM metallopeptidase with thrombospondin type 1 motif-5 (ADAMTS-5) and matrix metalloproteinase-13 (MMP-13) induced by IL-1\u03b2. Further investigation revealed that PVT1 was an endogenous sponge RNA, which directly bound to miR-140 and inhibited miR-140 expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>To sum up, this study showed that PVT1 promoted expressions of ADAMTS-5 and MMP-13 as a competing endogenous RNA (ceRNA) of miR-140 in OA, which eventually led to aggravation of ECM degradation, thus providing a new and promising strategy for the treatment of OA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13018-022-03114-4","type":"journal-article","created":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T13:02:17Z","timestamp":1649595737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Long noncoding RNA PVT1 promotes chondrocyte extracellular matrix degradation by acting as a sponge for miR-140 in IL-1\u03b2-stimulated chondrocytes"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8610-1552","authenticated-orcid":false,"given":"Nan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dake","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dane","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,10]]},"reference":[{"issue":"8","key":"3114_CR1","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/sms.13435","volume":"29","author":"M Mazor","year":"2019","unstructured":"Mazor M, Best TM, Cesaro A, Lespessailles E, Toumi H. Osteoarthritis biomarker responses and cartilage adaptation to exercise: a review of animal and human models. Scand J Med Sci Sports. 2019;29(8):1072\u201382.","journal-title":"Scand J Med Sci Sports"},{"issue":"12","key":"3114_CR2","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/ijms17122146","volume":"17","author":"E Charlier","year":"2016","unstructured":"Charlier E, Relic B, Deroyer C, Malaise O, Neuville S, Coll\u00e9e J, et al. Insights on molecular mechanisms of chondrocytes death in osteoarthritis. Int J Mol Sci. 2016;17(12):2146.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3114_CR3","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/jcm8111769","volume":"8","author":"D Rice","year":"2019","unstructured":"Rice D, McNair P, Huysmans E, Letzen J, Finan P. Best evidence rehabilitation for chronic pain part 5: osteoarthritis. J Clin Med. 2019;8(11):1769.","journal-title":"J Clin Med"},{"issue":"8","key":"3114_CR4","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/art.37990","volume":"65","author":"LT Le","year":"2013","unstructured":"Le LT, Swingler TE, Clark IM. Review: the role of microRNAs in osteoarthritis and chondrogenesis. Arthritis Rheum. 2013;65(8):1963\u201374.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3114_CR5","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1101\/gad.1915510","volume":"24","author":"S Miyaki","year":"2010","unstructured":"Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 2010;24(11):1173\u201385.","journal-title":"Genes Dev"},{"issue":"1","key":"3114_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13075-016-0997-y","volume":"18","author":"Y Liang","year":"2016","unstructured":"Liang Y, Duan L, Xiong J, Zhu W, Liu Q, Wang D, et al. E2 regulates MMP-13 via targeting miR-140 in IL-1\u03b2-induced extracellular matrix degradation in human chondrocytes. Arthritis Res Ther. 2016;18(1):105.","journal-title":"Arthritis Res Ther"},{"key":"3114_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2017.08.038","volume":"474","author":"D Lu","year":"2017","unstructured":"Lu D, Luo P, Wang Q, Ye Y, Wang B. lncRNA PVT1 in cancer: a review and meta-analysis. Clin Chim Acta. 2017;474:1\u20137.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"3114_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/os.12147","volume":"6","author":"D Xing","year":"2014","unstructured":"Xing D, Liang JQ, Li Y, Lu J, Jia HB, Xu LY, et al. Identification of long noncoding RNA associated with osteoarthritis in humans. Orthop Surg. 2014;6(4):288\u201393.","journal-title":"Orthop Surg"},{"key":"3114_CR9","doi-asserted-by":"publisher","first-page":"106052","DOI":"10.1016\/j.intimp.2019.106052","volume":"79","author":"X Lu","year":"2020","unstructured":"Lu X, Yu Y, Yin F, Yang C, Li B, Lin J, et al. Knockdown of PVT1 inhibits IL-1\u03b2-induced injury in chondrocytes by regulating miR-27b-3p\/TRAF3 axis. Int Immunopharmacol. 2020;79:106052.","journal-title":"Int Immunopharmacol."},{"issue":"3","key":"3114_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1753425919881778","volume":"26","author":"LB Ding","year":"2020","unstructured":"Ding LB, Li Y, Liu GY, Li TH, Li F, Guan J, et al. Long non-coding RNA PVT1, a molecular sponge of miR-26b, is involved in the progression of hyperglycemia-induced collagen degradation in human chondrocytes by targeting CTGF\/TGF-\u03b2 signal ways. Innate Immun. 2020;26(3):204\u201314.","journal-title":"Innate Immun"},{"issue":"5","key":"3114_CR11","doi-asserted-by":"publisher","first-page":"BSR20180576","DOI":"10.1042\/BSR20180576","volume":"38","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Zhao J, Guo X, She J, Liu Y. Long non-coding RNA PVT1, a molecular sponge for miR-149, contributes aberrant metabolic dysfunction and inflammation in IL-1\u03b2-simulated osteoarthritic chondrocytes. Biosci Rep. 2018;38(5):BSR20180576.","journal-title":"Biosci Rep."},{"issue":"7","key":"3114_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/dna.2017.3678","volume":"36","author":"Y Li","year":"2017","unstructured":"Li Y, Li S, Luo Y, Liu Y, Yu N. LncRNA PVT1 regulates chondrocyte apoptosis in osteoarthritis by acting as a sponge for miR-488-3p. DNA Cell Biol. 2017;36(7):571\u201380.","journal-title":"DNA Cell Biol"},{"issue":"6","key":"3114_CR13","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.3892\/etm.2017.4349","volume":"13","author":"N Yao","year":"2017","unstructured":"Yao N, Chen N, Xu X, Sun D, Liu W, Li G, et al. Protective effect of Shenmai injection on knee articular cartilage of osteoarthritic rabbits and IL-1\u03b2-stimulated human chondrocytes. Exp Ther Med. 2017;13(6):3013\u201320.","journal-title":"Exp Ther Med"},{"issue":"12","key":"3114_CR14","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1002\/jcb.23298","volume":"112","author":"P Verma","year":"2011","unstructured":"Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem. 2011;112(12):3507\u201314.","journal-title":"J Cell Biochem"},{"issue":"4","key":"3114_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.joca.2009.11.013","volume":"18","author":"AM Malfait","year":"2010","unstructured":"Malfait AM, Ritchie J, Gil AS, Austin JS, Hartke J, Qin W, et al. ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization. Osteoarthr Cartil. 2010;18(4):572\u201380.","journal-title":"Osteoarthr Cartil"},{"key":"3114_CR16","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.2174\/0929867326666181217153118","volume":"27","author":"Y Wan","year":"2020","unstructured":"Wan Y, Li W, Liao Z, Yan M, Chen X, Tang Z. Selective MMP-13 inhibitors: promising agents for the therapy of osteoarthritis. Curr Med Chem. 2020;27:3753\u201369.","journal-title":"Curr Med Chem"},{"issue":"1","key":"3114_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13075-017-1454-2","volume":"19","author":"H Li","year":"2017","unstructured":"Li H, Wang D, Yuan Y, Min J. New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis. Arthritis Res Ther. 2017;19(1):248.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3114_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/08923973.2019.1637890","volume":"41","author":"H Li","year":"2019","unstructured":"Li H, Peng Y, Wang X, Sun X, Yang F, Sun Y, et al. Astragaloside inhibits IL-1\u03b2-induced inflammatory response in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice. Immunopharmacol Immunotoxicol. 2019;41(4):497\u2013503.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"4","key":"3114_CR19","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s10753-017-0558-9","volume":"40","author":"W Zheng","year":"2017","unstructured":"Zheng W, Tao Z, Cai L, Chen C, Zhang C, Wang Q, et al. Chrysin attenuates IL-1\u03b2-induced expression of inflammatory mediators by suppressing NF-\u03baB in human osteoarthritis chondrocytes. Inflammation. 2017;40(4):1143\u201354.","journal-title":"Inflammation"},{"key":"3114_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.intimp.2017.06.017","volume":"50","author":"Z Feng","year":"2017","unstructured":"Feng Z, Zheng W, Li X, Lin J, Xie C, Li H, et al. Cryptotanshinone protects against IL-1\u03b2-induced inflammation in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice. Int Immunopharmacol. 2017;50:161\u20137.","journal-title":"Int Immunopharmacol"},{"key":"3114_CR21","doi-asserted-by":"publisher","first-page":"561459","DOI":"10.1155\/2014\/561459","volume":"2014","author":"P Wojdasiewicz","year":"2014","unstructured":"Wojdasiewicz P, Poniatowski \u0141A, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat Inflamm. 2014;2014:561459.","journal-title":"Mediat Inflamm."},{"issue":"1","key":"3114_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2013.06.020","volume":"154","author":"I Ulitsky","year":"2013","unstructured":"Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154(1):26\u201346.","journal-title":"Cell"},{"issue":"5","key":"3114_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jbspin.2016.09.006","volume":"84","author":"SD Jiang","year":"2017","unstructured":"Jiang SD, Lu J, Deng ZH, Li YS, Lei GH. Long noncoding RNAs in osteoarthritis. Joint Bone Spine. 2017;84(5):553\u20136.","journal-title":"Joint Bone Spine"},{"issue":"21","key":"3114_CR24","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1007\/s00018-019-03222-1","volume":"76","author":"K Jin","year":"2019","unstructured":"Jin K, Wang S, Zhang Y, Xia M, Mo Y, Li X, et al. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis. Cell Mol Life Sci. 2019;76(21):4275\u201389.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3114_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbrc.2015.12.101","volume":"471","author":"M Cui","year":"2016","unstructured":"Cui M, You L, Ren X, Zhao W, Liao Q, Zhao Y. Long non-coding RNA PVT1 and cancer. Biochem Biophys Res Commun. 2016;471(1):10\u20134.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3114_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"8","key":"3114_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/cells7080092","volume":"7","author":"CJ Malemud","year":"2018","unstructured":"Malemud CJ. MicroRNAs and osteoarthritis. Cells. 2018;7(8):92.","journal-title":"Cells"},{"issue":"6","key":"3114_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2174\/138920291506150106154338","volume":"15","author":"T Trzeciak","year":"2014","unstructured":"Trzeciak T, Czarny-Ratajczak M. MicroRNAs: important epigenetic regulators in osteoarthritis. Curr Genomics. 2014;15(6):481\u20134.","journal-title":"Curr Genomics"},{"issue":"5","key":"3114_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00011-012-0438-6","volume":"61","author":"ZJ Liang","year":"2012","unstructured":"Liang ZJ, Zhuang H, Wang GX, Li Z, Zhang HT, Yu TQ, et al. MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1\u03b2-stimulated human articular chondrocyte C28\/I2 cells. Inflamm Res. 2012;61(5):503\u20139.","journal-title":"Inflamm Res"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03114-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-022-03114-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03114-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T13:02:49Z","timestamp":1649595769000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-022-03114-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,10]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3114"],"URL":"https:\/\/doi.org\/10.1186\/s13018-022-03114-4","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,10]]},"assertion":[{"value":"11 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of Guangdong Second Traditional Chinese Medicine Hospital. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee. All the patients signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}